These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18042326)

  • 1. Testosterone, diabetes mellitus, and the metabolic syndrome.
    Spark RF
    Curr Urol Rep; 2007 Nov; 8(6):467-71. PubMed ID: 18042326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives.
    Salzano A; D'Assante R; Heaney LM; Monaco F; Rengo G; Valente P; Pasquali D; Bossone E; Gianfrilli D; Lenzi A; Cittadini A; Marra AM; Napoli R
    Endocrine; 2018 Aug; 61(2):194-203. PubMed ID: 29572708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testosterone and mortality].
    Stárka L
    Vnitr Lek; 2016; 62(9 Suppl 3):127-130. PubMed ID: 27734705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.
    Shabsigh R; Arver S; Channer KS; Eardley I; Fabbri A; Gooren L; Heufelder A; Jones H; Meryn S; Zitzmann M
    Int J Clin Pract; 2008 May; 62(5):791-8. PubMed ID: 18266714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know.
    Tamler R; Deveney T
    Postgrad Med; 2010 Nov; 122(6):165-75. PubMed ID: 21084793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?
    Kapoor D; Jones TH
    Drugs Aging; 2008; 25(5):357-69. PubMed ID: 18447401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.
    Bogefors C; Isaksson S; Bobjer J; Kitlinski M; Leijonhufvud I; Link K; Giwercman A
    Andrology; 2017 Jul; 5(4):711-717. PubMed ID: 28544654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
    Saad F
    Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities.
    Miner MM; Sadovsky R
    Cleve Clin J Med; 2007 May; 74 Suppl 3():S38-46. PubMed ID: 17549824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex association between metabolic syndrome and male hypogonadism.
    Dimopoulou C; Goulis DG; Corona G; Maggi M
    Metabolism; 2018 Sep; 86():61-68. PubMed ID: 29656047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
    Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
    Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Lapauw B; Kaufman JM
    Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An idiopathic hypogonadotropic hypogonadism patient with metabolic disorder and diabetes: case report.
    Zhang MN; Su B; Qian CH; Bu L; Cheng XY; Li WJ; Qu S
    Asian J Androl; 2015; 17(2):341-2. PubMed ID: 25337838
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus.
    Ogbera AO
    West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.